Eisai
4523.T
#2137
Rank
$9.01 B
Marketcap
$31.95
Share price
3.95%
Change (1 day)
11.90%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): $0.37 Billion USD

According to Eisai's latest financial reports the company's current earnings are $5.44 Billion USD. In 2025 the company made an earning of $0.42 Billion USD a decrease over its 2024 earnings that were of $0.53 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.37 B-11.11%
2025 $0.42 B-20.48%
2024 $0.53 B2.42%
2023 $0.52 B-2404.04%
2022 -$22.76 Million-103.6%
2021 $0.63 B-39.81%
2020 $1.05 B7.44%
2019 $0.97 B17.22%
2018 $0.83 B86.16%
2017 $0.44 B-23.52%
2016 $0.58 B26.97%
2015 $0.46 B22.3%
2014 $0.37 B-46.07%
2013 $0.70 B-21.85%
2012 $0.89 B-20.59%
2011 $1.12 B-8.91%
2010 $1.23 B19.21%
2009 $1.03 B